Aug 03rd 2012 - Edison Investment Research today published a report on Imperial Innovations (IVO.L, LSE:IVO, LON:IVO) entitled "Investing In A Start-up Portfolio". In summary, the report says:
Imperial Innovations offers the potential for significant value creation from the maturation of, and realisations from, its portfolio of equity holdings in early-stage biotech and technology companies. Its investment strategy is to be directly involved in the management of companies from start-up, while making progressively larger investments over time. Two portfolio companies, Circassia and Nexeon, have reached the stage where significant investments have been made. This report highlights the portfolio and profiles some of the leading investee companies.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »